<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-1N5AX3SR</identifier><date>2019</date><creator>Preložnik-Zupan, Irena</creator><relation>documents/doc/1/URN_NBN_SI_doc-1N5AX3SR_001.pdf</relation><relation>documents/doc/1/URN_NBN_SI_doc-1N5AX3SR_001.txt</relation><format format_type="issue">2</format><format format_type="volume">70</format><format format_type="type">article</format><format format_type="extent">str. 119-124</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID_HOST">6142124</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-1N5AX3SR</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">anemija</subject><subject language_type_id="slv">bledica</subject><subject language_type_id="slv">eritrociti</subject><subject language_type_id="slv">utrujenost</subject><subject language_type_id="slv">zmanjšana koncentracija hemoglobina</subject><title>Anaemia</title><title>Anemija</title><title>disease evaluation and risk factors</title><title>prepoznavanje bolezni in dejavniki tveganja</title></Record>